Related Experiment Video
Updated: May 25, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Canonical transient receptor potential channels in diabetes
Sarabeth Graham1, Joseph P Yuan, Rong Ma
1Department of Integrative Physiology and Cardiovascular Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Experimental Biology and Medicine (Maywood, N.J.)
|January 28, 2012
Summary
Canonical transient receptor potential (TRPC) channels are implicated in diabetes complications. This review explores TRPC
Area of Science:
- Molecular Biology
- Physiology
- Pathology
Background:
- Canonical transient receptor potential (TRPC) channels regulate intracellular calcium signaling.
- TRPC channel function is crucial in various cellular processes.
- Recent research investigates TRPC protein involvement in disease states.
Purpose of the Study:
- To review the role of TRPC proteins in diabetes and its complications.
- To summarize current findings on TRPC involvement in diabetic nephropathy and vasculopathy.
- To discuss the potential of TRPC proteins as therapeutic targets for diabetes-associated diseases.
Main Methods:
- Literature review of existing studies on TRPC proteins and diabetes.
- Synthesis of findings from various research groups, including the authors'.
- Outline of underlying mechanisms contributing to diabetic complications.
Main Results:
- TRPC proteins play a significant role in the development of diabetic complications.
- Specific TRPC isoforms are implicated in diabetic nephropathy and vasculopathy.
- Mechanisms underlying these complications involve TRPC-mediated signaling pathways.
Conclusions:
- TRPC proteins are critically involved in the pathogenesis of diabetes-associated diseases.
- Targeting TRPC proteins may offer a novel therapeutic strategy for managing diabetic complications.
- Further research is warranted to fully elucidate TRPC function in diabetes.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.